Simulations Plus price target raised to $60 from $55 at BTIG

BTIG raised the firm’s price target on Simulations Plus to $60 from $55 and keeps a Buy rating on the shares after hosting a non-deal roadshow with its CEO Shawn O’Conner. Investor interest in the stock and space is high and sentiment is generally positive, the analyst tells investors in a research note, adding that the firm also learned that AI is not competing with Simulations Plus but rather several AI businesses have become clients of of the company. Growth in pharma R&D spend can vary significantly by business, but the overall trends are improving, which should drive increased demand, BTIG stated.